Our mission is to make medicines that help people live longer, healthier, more active lives. To achieve this mission, Lilly works with various individuals and organizations to improve patient outcomes and the healthcare system.
We are proud of the support we provide in collaboration with others to help advance the treatment and care of those battling illnesses. We also believe transparency is critical to rebuilding trust in our industry. Lilly was the first company (in 2004) to establish an online database of our clinical trial results, and the first company (in 2007) to establish a public registry of our grants and charitable contributions. And, in 2009, we became the first company to report our payments to physicians for speaking and advising services. Lilly strives to be a leading voice and example in transparency efforts in the biopharmaceutical industry.
The links below provide more information on our disclosure efforts:
o Educational Grants and charitable contributions to U.S. health care-related organizations
o Political Financial Support
o Report on Charitable Giving
o Payments to U.S. Physicians
Lilly Clinical Trial Registry: U.S. Clinical Trials Listing and Trial Data
In 2004, Lilly became the first company to voluntarily make public our U.S. clinical trials and our clinical trials data in the Lilly Clinical Trial Registry.
Lilly Grant Registry: Educational Grants to Institutions and Charitable Contributions to Health care-related Organizations in the U.S.
In 2007, Lilly became the first biopharmaceutical company to publicly report the funding we provide in the U.S. to institutions in the form of educational grants and charitable contributions to support medical education, patient education, and other worthy activities that we believe increase health care knowledge and improve patient care. The Lilly Grant Office administers this program.
Lilly Public Affairs and Political Contributions
Lilly supports candidates of any party who support public policies that contribute to pharmaceutical innovation and the health needs of patients. Lilly employees in the U.S. may choose to make voluntary contributions to the Lilly Political Action Committee (PAC), an entity funded solely by employee contributions. For more information see Public Affairs or see the report on Political Financial Support.
Lilly Foundation: Product and Cash Contributions: Report on Charitable Giving
In keeping with the Lilly family’s commitment to good corporate responsibility, Lilly contributes at the level of the most generous companies worldwide – a goal it achieves annually through product and cash contributions. See Lilly Foundation or see the Lilly Foundation Report on Charitable Giving.
Lilly Physician Payment Registry: Disclosures of Payments Provided to U.S. Physicians
When doctors work together with the pharmaceutical industry, patients benefit– because collaboration makes new medicines possible, delivers quality health education, and provides better insights into unmet patient needs. Lilly is now tracking aspects of our financial relationships with physicians in the U.S. as required by a Corporate Integrity Agreement we entered into with the Office of the Inspector General of the U.S. Department of Health and Human Services in February 2009. Lilly discloses payments and other types of value provided to all U.S.-based physicians in the Physician Payment Registry. To learn more, visit the Lilly Physician Payment Registry website.
